NEXTBIOMEDICAL Secures Health Canada Approval for Nexsphere-F™ in Musculoskeletal Pain Embolization

NEXTBIOMEDICAL CO., LTD. (KOSDAQ: 389650), an innovative medical device company based in South Korea, announced today that Nexsphere-F™, the company's novel fast resorbable microsphere for ...
KRQE Blogs

CD Formulation Empowers High-volume Manufacturing of Microspheres

CD Formulation is well-prepared to serve the industry by offering efficient and effective solutions for the mass fabrication of microspheres. SHIRLEY, NY, UNITED ...